Weight loss medications are indicated for patients with a BMI of 27-29.9 plus one or more weight-related conditions (such as Type 2 diabetes, high cholesterol, high blood pressure, heart disease, obstructive sleep apnea, symptomatic osteoarthritis, hepatic steatosis, mental health disorders, and difficulty with physical function) or a BMI 30
Shes looking for the familiarity of an oral option Wants to look her best Age: 20s-30s BMI: 30-34 kg/m Who is this patient
However, Rybelsus is not approved for weight loss
The ChronoFast trial, led by Professor Olga Ramich and published in Science Translational Medicine, did something most previous studies had failed to do: it controlled for calorie intake
BPC-157 is widely renowned for its ability to accelerate angiogenesis (the creation of new blood vessels) and radically speed up the healing of tendons, ligaments, and gut lining